Award notice Supplies
261A000098 - C.Central Medicamentos 2026 - 2026/0312
Notice published in Portuguese. The AI analysis summarises it for you in your language.
- Public buyer
- Unidade Local de Saúde Santa Maria, E.P.E.
Lisboa - Place of performance
- Lisboa
- Estimated value
- €58,860 excl. VAT
- Amount awarded
- €58,860 excl. VAT
- Planned end of contract
- 28 January 2027
likely re-tender around October 2026 - Bids received
- 1
- Procedure
- Open procedure
Any company may submit a bid. - Publication
- 10 August 2026
- Notice language
- Portuguese
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
C.Central Medicamentos 2026 - 2026/0312
Awarded to
3 lots
- Lote 5 - DENOsumab SOL INJ 60 MG/ 1ML SC BIOSSIMILAR SERINGA 1 ML (OSVYRTI)
- Lote 9 - DENOsumab SOL INJ SC BIOSSIMILAR 120 MG (JUBEREQ)
- Lote 11 - DENOsumab SOL INJ SC BIOSSIMILAR 120 MG (JUBEREQ)
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33652200
Winning prices for comparable contracts
- A quarter below
- €58,860
- Median
- €71,125
- A quarter above
- €382,013
Amounts awarded (excl. VAT) over the last 3 years for 5 contracts in the same CPV group (3365…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| 261A000098 - C.Central Medicamentos 2026 - 2026/0312 - ECULIzumab Unidade Local de Saúde Santa Maria, E.P.E. · 10 August 2026 |
SAMSUNG BIOEPIS NL B. V | €382,013 |
| 261A000098 - C.Central Medicamentos 2026 - 2026/0312 - ECULIzumab Unidade Local de Saúde Santa Maria, E.P.E. · 10 August 2026 |
SAMSUNG BIOEPIS NL B. V | €382,013 |
| 261A000098 - C.Central Medicamentos 2026 - 2026/0312 (-BEVACIzumab ) Unidade Local de Saúde Santa Maria, E.P.E. · 13 July 2026 |
Cencora 3PL Portugal | €47,394 |
| 261A000098 - C.Central Medicamentos 2026 - 2026/0312 (-BEVACIzumab ) Unidade Local de Saúde Santa Maria, E.P.E. · 13 July 2026 |
CICLUM FARMA UNIPESSOAL, LDA | €71,125 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 550788-2026.